(Q47996634)

7 February 2018

title

The use of recombinant ovine IL-1beta and TNF-alpha as natural adjuvants and their physiological effects in vivo (English)

1 reference

7 February 2018

author

Heng Fong Seow

2

1 reference

7 February 2018

Marshall Lightowlers

3

1 reference

7 February 2018

Charles Gauci

5

1 reference

7 February 2018

author name string

Rothel JS

1

1 reference

7 February 2018

Parry BW

4

1 reference

7 February 2018

Hurst L

6

1 reference

7 February 2018

Mucha MJ

7

1 reference

7 February 2018

Corner LA

8

1 reference

7 February 2018

Wood PR

9

1 reference

7 February 2018

publication date

1 April 1998

1 reference

7 February 2018

Immunology & Cell Biology

published in

1 reference

7 February 2018

volume

76

1 reference

7 February 2018

issue

2

1 reference

7 February 2018

page(s)

167-172

1 reference

7 February 2018

Present status of the use of cytokines as adjuvants with vaccines to protect against infectious diseases

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1998.00729.X

Endothelial cell interactions with granulocytes: tethering and signaling molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1998.00729.X

IL-4 and IL-2 upregulate the expression of antigen B7, the B cell counterstructure to T cell CD28: an amplification mechanism for T-B cell interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1998.00729.X

Induction of TH1 and TH2 responses: a key role for the 'natural' immune response?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1998.00729.X

Towards a comprehensive view of immunoglobulin class switching

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1998.00729.X

Cytokines as immunological adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1998.00729.X

Cytokines as potential vaccine adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1998.00729.X

Vaccination against ovine cysticercosis using a defined recombinant antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1998.00729.X

Expression and purification of recombinant ovine interleukin-1 beta from Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1998.00729.X

Expression, biological activity and kinetics of production of recombinant ovine TNF-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1998.00729.X

Plasma tumor necrosis factor-alpha during long-term endotoxemia in awake sheep.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1998.00729.X

Human recombinant tumor necrosis factor alpha infusion mimics endotoxemia in awake sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1998.00729.X

The pathophysiology of tumor necrosis factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1998.00729.X

Immunopotentiation of bovine respiratory disease virus vaccines by interleukin-1 beta and interleukin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1998.00729.X

Recombinant cytokines as immunological adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1998.00729.X

Modulation of antiviral immune responses by exogenous cytokines: effects of tumour necrosis factor-alpha, interleukin-1 alpha, interleukin-2 and interferon-gamma on the immunogenicity of an inactivated rabies vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.1998.00729.X

10.1046/J.1440-1711.1998.00729.X

21 January 2018

Identifiers

DOI

1 reference

7 February 2018

1 reference

7 February 2018